Skip to content
Home/Companies/Pharma/Archimica
Archimica

Archimica

Pharma·Italy·Exited 2023·Held 4yr
Entry
2019
Hold
4yr
Exit
2023

Who owns Archimica?

Archimica was owned by LIVIA Group through LIVIA Corporate Development (2013 vintage) from 2019 to 2023, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

LIVIA Group
Investor
LIVIA Group
LIVIA Corporate Development · 2013 · Evergreen

Key facts

HQItaly
SectorPharma
StatusAcquired
Websitewww.archimica.com
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2023

More from LIVIA Corporate Development

Other portfolio companies in the same fund.

Westpole
Exited 2023
SoftwareItaly· 2020
to
ALUCOM
Alucom
Exited 2025
IndustrialsGermany· 2018
to
Baden Board and Packaging
Exited 2019
IndustrialsGermany· 2018
to
Tingari
Exited 2022
Business ServicesFrance· 2018
to
Refel
Exited 2022
IndustrialsItaly· 2017
to
Coflace Food
Exited 2017
ConsumerNetherlands· 2016
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
Laboratoires Delbert
Active
SocadifFrance
Pharmathen
Active
Partners GroupGreece
AMW
AMW
Active
SHS Gesellschaft für BeteiligungsmanagementGermany· 2026
Basic Pharma
Active
SHS Gesellschaft für BeteiligungsmanagementNetherlands· 2026
Biogaran
Biogaran
Active
Bpifrance InvestissementFrance· 2026
Track Archimica

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Archimica?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Archimica.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue